[Remote] Clinical Research Lead - Immunology, Neurodegeneration, Cardiometabolic Health, Investigator Engagement at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess deep therapeutic and scientific knowledge, strategic agility, and the ability to influence investigators. A strong understanding of clinical trial execution, investigator engagement, and site performance management is essential. Experience in immunology, neurodegeneration, or cardiometabolic health is required, along with the capability to build strong, enduring relationships with investigators and internal teams.

Responsibilities

The Clinical Research Lead will drive the execution of clinical trials by managing investigator engagement and site performance, ensuring high-performing sites prioritize Lilly's portfolio. They will serve as a scientific ambassador to investigators, elevating protocol understanding and co-developing enrollment strategies. The role involves building trusted partnerships with investigators, collaborating with internal teams to shape development strategies, and potentially representing Investigator Engagement with regulatory and external bodies. Responsibilities also include managing the full spectrum of investigator engagement from identification to closeout, leading site-level strategy and risk planning, driving inspection readiness, and collaborating across functions to resolve operational barriers.

Skills

Clinical trial execution

Investigator engagement

Site performance management

Therapeutic knowledge

Scientific knowledge

Enrollment strategies

Relationship building

Clinical Development

Medical Affairs

Regulatory affairs

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free